Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Gross margin
Cencora, Inc.'s gross margin over the twelve months to 30 September 2026 was 4.11%. Over the past ten years it has ranged from 2.60% (fiscal 2015) to 4.11% (fiscal 2026) — the current reading is the highest in ten years. That is below the Medical Distribution industry median of 5.74% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 4.11% | 0.54 |
| FY2025 | 3.57% | 0.20 |
| FY2024 | 3.37% | (0.05) |
| FY2023 | 3.42% | (0.06) |
| FY2022 | 3.48% | 0.24 |
| FY2021 | 3.24% | 0.51 |
| FY2020 | 2.73% | (0.13) |
| FY2019 | 2.86% | 0.11 |
| FY2018 | 2.75% | (0.22) |
| FY2017 | 2.97% | 0.06 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 4.08% | (0.18) |
| Jun 2026 | 4.26% | (0.32) |
| Mar 2026 | 4.58% | 1.00 |
| Dec 2025 | 3.58% | 0.05 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ACH Accendra Health, Inc. compare | 44.8% |
| FOCL FocalTherics compare | 44.5% |
| HSIC Henry Schein, Inc. compare | 31.6% |
| COSM Cosmos Health Inc. compare | 10.3% |
| YI 111, Inc. Sponsored ADR compare | 5.74% |
| COR Cencora, Inc. | 4.11% |
| CAH Cardinal Health, Inc. compare | 3.90% |
| MCK McKesson Corporation compare | 3.67% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| Medical Distribution industry median | 5.74% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement